Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02046187 · ClinicalTrials.gov registry record · Phase 1
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
A Phase 1 study, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT02046187 is a Phase 1 study that was terminated before completion, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 14 participants.
The verdict
NCT02046187, a Phase 1 study, was terminated before completion, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study aims to see if reducing blood sugar and increasing ketones (a metabolic product that comes from using fats for energy) can increase survival and enhance the the effects of standard radiation and chemotherapy treatments used to treat glioblastoma multiforme (GBM). These changes occur from use of a ketogenic diet. This research has 2 goals: 1. Show that patients can tolerate the diet and maintain low blood glucose and high blood ketone levels. 2. Show if this diet enhances the effectiveness of standard treatment by prolonging survival of patients with a GBM.
Interventions
- DRUG Temozolomide
- RADIATION Radiation therapy
- DIETARY_SUPPLEMENT Ketogenic Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-10 |
| Est. Completion | 2017-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02046187
The ClinicalTrials.gov registry entry for NCT02046187 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Temozolomide is the first listed.
NCT02046187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02046187 about?
NCT02046187 is a clinical study titled "Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma". This study aims to see if reducing blood sugar and increasing ketones (a metabolic product that comes from using fats for energy) can increase survival and enhance the the effects of standard radiation and chemotherapy treatments used to treat glioblastoma multiforme (GBM). These changes occur from ...
What is the current status of trial NCT02046187?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2013-10. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02046187?
The interventions under investigation include: Temozolomide (DRUG), Radiation therapy (RADIATION), Ketogenic Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02046187?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.